Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of botulinum toxin A for acne management
TCTR20231025002Phase 4Completed
- Sponsor
- Srinakharinwirot University
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in acne vulgaris, sponsored by Srinakharinwirot University. Started Jun 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20231025002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231025002.